Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel
- PMID: 23571109
- PMCID: PMC3699065
- DOI: 10.1093/hmg/ddt160
Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel
Abstract
Ovarian cancer remains the leading cause of death in women with gynecologic malignancies, despite surgical advances and the development of more effective chemotherapeutics. As increasing evidence indicates that clear-cell ovarian cancer may have unique pathogenesis, further understanding of molecular features may enable us to begin to understand the underlying biology and histology-specific information for improved outcomes. To study epigenetics in clear-cell ovarian cancer, fresh frozen tumor DNA (n = 485) was assayed on Illumina Infinium HumanMethylation450 BeadChips. We identified a clear-cell ovarian cancer tumor methylation profile (n = 163) which we validated in two independent replication sets (set 1, n = 163; set 2, n = 159), highlighting 22 CpG loci associated with nine genes (VWA1, FOXP1, FGFRL1, LINC00340, KCNH2, ANK1, ATXN2, NDRG21 and SLC16A11). Nearly all of the differentially methylated CpGs showed a propensity toward hypermethylation among clear-cell cases. Several loci methylation inversely correlated with tumor gene expression, most notably KCNH2 (HERG, a potassium channel) (P = 9.5 × 10(-7)), indicating epigenetic silencing. In addition, a predicted methylation class mainly represented by the clear-cell cases (20 clear cell out of 23 cases) had improved survival time. Although these analyses included only 30 clear-cell carcinomas, results suggest that loss of expression of KCNH2 (HERG) by methylation could be a good prognostic marker, given that overexpression of the potassium (K(+)) channel Eag family members promotes increased proliferation and results in poor prognosis. Validation in a bigger cohort of clear-cell tumors of the ovary is warranted.
Figures

Similar articles
-
The Eag potassium channel as a new prognostic marker in ovarian cancer.Diagn Pathol. 2010 Dec 7;5:78. doi: 10.1186/1746-1596-5-78. Diagn Pathol. 2010. PMID: 21138547 Free PMC article.
-
DNA Methylation Profiles of Ovarian Clear Cell Carcinoma.Cancer Epidemiol Biomarkers Prev. 2022 Jan;31(1):132-141. doi: 10.1158/1055-9965.EPI-21-0677. Epub 2021 Oct 25. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 34697060 Free PMC article.
-
Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.Epigenetics. 2014 Dec;9(12):1577-87. doi: 10.4161/15592294.2014.983374. Epigenetics. 2014. PMID: 25625843 Free PMC article.
-
Increased expression of TET3 predicts unfavorable prognosis in patients with ovarian cancer-a bioinformatics integrative analysis.J Ovarian Res. 2019 Oct 27;12(1):101. doi: 10.1186/s13048-019-0575-4. J Ovarian Res. 2019. PMID: 31656201 Free PMC article. Review.
-
Epigenetic regulation in ovarian cancer.Int Rev Cell Mol Biol. 2024;387:77-98. doi: 10.1016/bs.ircmb.2024.03.006. Epub 2024 May 13. Int Rev Cell Mol Biol. 2024. PMID: 39179349 Review.
Cited by
-
DNA methylation-based profiling reveals distinct clusters with survival heterogeneity in high-grade serous ovarian cancer.Clin Epigenetics. 2021 Oct 13;13(1):190. doi: 10.1186/s13148-021-01178-3. Clin Epigenetics. 2021. PMID: 34645493 Free PMC article.
-
Monocarboxylate Transporters (SLC16): Function, Regulation, and Role in Health and Disease.Pharmacol Rev. 2020 Apr;72(2):466-485. doi: 10.1124/pr.119.018762. Pharmacol Rev. 2020. PMID: 32144120 Free PMC article. Review.
-
DNA methylation changes in epithelial ovarian cancer histotypes.Genomics. 2015 Dec;106(6):311-21. doi: 10.1016/j.ygeno.2015.09.001. Epub 2015 Sep 10. Genomics. 2015. PMID: 26363302 Free PMC article. Review.
-
Ataxin-2: a powerful RNA-binding protein.Discov Oncol. 2024 Jul 22;15(1):298. doi: 10.1007/s12672-024-01158-y. Discov Oncol. 2024. PMID: 39039334 Free PMC article. Review.
-
hERG1 potassium channel in cancer cells: a tool to reprogram immortality.Eur Biophys J. 2016 Oct;45(7):649-655. doi: 10.1007/s00249-016-1169-3. Epub 2016 Sep 20. Eur Biophys J. 2016. PMID: 27649700 Review.
References
-
- Del Carmen M.G., Birrer M., Schorge J.O. Clear cell carcinoma of the ovary: a review of the literature. Gynecol. Oncol. 2012;126:481–490. doi:10.1016/j.ygyno.2012.04.021. - DOI - PubMed
-
- Pearce C.L., Templeman C., Rossing M.A., Lee A., Near A.M., Webb P.M., Nagle C.M., Doherty J.A., Cushing-Haugen K.L., Wicklund K.G., et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol. 2012;13:385–394. doi:10.1016/S1470-2045(11)70404-1. - DOI - PMC - PubMed
-
- Prat J. Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features. Virchows Arch. 2012;460:237–249. doi:10.1007/s00428-012-1203-5. - DOI - PubMed
-
- Ozols R.F. Systemic therapy for ovarian cancer: current status and new treatments. Semin. Oncol. 2006;33:S3–S11. doi:10.1053/j.seminoncol.2006.03.011. - DOI - PubMed
-
- Romero I., Bast R.C., Jr Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy. Endocrinology. 2012;153:1593–1602. doi:10.1210/en.2011-2123. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials